Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico

Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion

Quantifying transcriptome diversity: a review

CoSIA: an R Bioconductor package for CrOss Species Investigation and Analysis

Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes

Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates

Computational Advancements in Drug Repurposing for Cancer Combination Therapy Prediction

Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles

Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers

CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability

Ten simple rules for using public biological data for your research

CINmetrics: An R package for chromosomal instability analysis

Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics

A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1

We are back with another update! Thank you for taking the time to check in on how our lab is evolving and growing! It has been almost two years since our last update, so a lot has happened!

It has been an eventful eight months. Our first and most recent entry was posted in March of this year, and much has happened since then! While COVID-19 has had a tragic negative effect on the world around us, we have been very fortunate to have had plenty of positive events as well.

Welcome to the new Lasseigne Lab website! While still under construction, we wanted to share a first post about our new team!